Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1097/MD.0000000000002524 http://scihub22266oqcxt.onion/10.1097/MD.0000000000002524 C4998269!4998269!26817895     free     free     free Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Medicine+(Baltimore) 2016 ; 95 (3): ä Nephropedia Template TP {{tp|p=26817895|t=2016. Selective Retina Therapy in Patients With Chronic Central Serous Chorioretinopathy: A Pilot Study |pdf=|usr=}}{{26817895}} gab.com Text Selective Retina Therapy in Patients With Chronic Central Serous Chorioretinopathy: A Pilot Study JO: Medicine (Baltimore) http://www.kidney.de/pget.php?&tw=1&pmid=26817895 #FOAvip We evaluated visual outcomes, changes of maximum macular thickness (MMT) and subretinal fluid (SRF), and safety in patients with chronic central serous chorioretinopathy (CSC) after treatment with selective retina therapy (SRT). Retrospective cohort study of patients with chronic CSC presenting to a university-based hospital from January 2014 through January 2015 was conducted. A total of 12 eyes of 12 patients with chronic CSC lasting for at least 3 months was recruited. The follow-up period ranged from 3 to 12 months. Following evaluation of test spots at temporal arcades, SRT (Q-switched neodymium-doped yttrium lithium fluoride [Nd:YLF] laser; wavelength, 527?nm, pulse duration, 1.7?microsececond) was applied to the surrounding areas of leakage observed on fluorescein angiogram and/or pigment epithelial detachment (PED). Changes in best-correct visual acuity (BCVA), MMT, and SRF and macular sensitivity (MS) by microperimetry (MP) were evaluated. Eyes received treatment in a mean of 3.83 spots at the pulse energy of 65 to 90??J. Mean BCVA (logMAR) improved from 0.23?±?0.12 at baseline to 0.14?±?0.13 at 3 months. MMT decreased from 341.4?±?85.5??m at baseline to 236.0?±?57.9??m at 3 months. SRF completely resolved in 75% (9 eyes) at 3 months. Large PEDs (2 eyes) were flattened at 3 months. Retreatment was performed in 4 eyes. MP showed no evidence of scotoma around SRT-treated lesions. SRT treatment targeting the surrounding area of leakage point showed favorable visual and structural outcomes in chronic CSC patients without the risk of scotoma. Twit Text FOAVip Selective Retina Therapy in Patients With Chronic Central Serous Chorioretinopathy: A Pilot Study ????Medicine (Baltimore) http://www.kidney.de/pget.php?&tw=1&pmid=26817895 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=26817895 #FOAvip English Wikipedia <ref>{{Cite pmid|26817895}}</ref> Selective Retina Therapy in Patients With Chronic Central Serous Chorioretinopathy: A Pilot Study #MMPMID26817895 Kang S; Park YG; Kim JR; Seifert E; Dirk TK; Ralf B; Roh YJ Medicine (Baltimore) 2016[Jan]; 95 (3): ä PMID26817895show ga We evaluated visual outcomes, changes of maximum macular thickness (MMT) and subretinal fluid (SRF), and safety in patients with chronic central serous chorioretinopathy (CSC) after treatment with selective retina therapy (SRT). Retrospective cohort study of patients with chronic CSC presenting to a university-based hospital from January 2014 through January 2015 was conducted. A total of 12 eyes of 12 patients with chronic CSC lasting for at least 3 months was recruited. The follow-up period ranged from 3 to 12 months. Following evaluation of test spots at temporal arcades, SRT (Q-switched neodymium-doped yttrium lithium fluoride [Nd:YLF] laser; wavelength, 527?nm, pulse duration, 1.7?microsececond) was applied to the surrounding areas of leakage observed on fluorescein angiogram and/or pigment epithelial detachment (PED). Changes in best-correct visual acuity (BCVA), MMT, and SRF and macular sensitivity (MS) by microperimetry (MP) were evaluated. Eyes received treatment in a mean of 3.83 spots at the pulse energy of 65 to 90??J. Mean BCVA (logMAR) improved from 0.23?±?0.12 at baseline to 0.14?±?0.13 at 3 months. MMT decreased from 341.4?±?85.5??m at baseline to 236.0?±?57.9??m at 3 months. SRF completely resolved in 75% (9 eyes) at 3 months. Large PEDs (2 eyes) were flattened at 3 months. Retreatment was performed in 4 eyes. MP showed no evidence of scotoma around SRT-treated lesions. SRT treatment targeting the surrounding area of leakage point showed favorable visual and structural outcomes in chronic CSC patients without the risk of scotoma. äSelective Retina Therapy in Patients With Chronic Central Serous Chori(epmc).pdf DeepDyve Pubget Overpricing